Article Text


Small bowel II
PWE-113 Coeliac serology at a large district general hospital, results in 6394 patients
  1. K Kodjabashia1,
  2. S A Haider1,
  3. C Crossland2,
  4. V Lashmar3,
  5. S D McLaughlin1
  1. 1Department of Gastroenterology, Royal Bournemouth Hospital, Bournemouth, UK
  2. 2Department of Histopathology, Royal Bournemouth Hospital, Bournemouth, UK
  3. 3University of Southampton, Southampton, UK


Introduction Coeliac disease has an estimated UK prevalence of 1% and is an important, common cause of many gastro-intestinal and non-gastro-intestinal symptoms. Coeliac serological blood tests are commonly performed in both primary and secondary care. Positive coeliac serology occurs in patients with: (i) Coeliac disease, (ii) Latent Coeliac disease, (iii) Dermatitis herpetiformis. The UK national institute for health and clinical excellence (NICE),1 British society of gastroenterology guidelines (BSG) and American Gastroenterology Association (AGA)2 guidelines recommend that all patients with positive coeliac serology undergo duodenal biopsy since diagnosis of coeliac disease requires both positive serology and typical histological findings.

Methods We reviewed the results of all coeliac serology tests performed at our hospital laboratory in the previous 12 months. The case notes for all patients with positive results were reviewed.

Results 6394 endomysial antibody results were performed on adult patients between 1 October 2010 and 30 September 2011. 100 (1.6%) were positive. Of these 67 (67.0%) underwent biopsy. 50 (74.6%) had histological evidence of coeliac disease; 5 (7.5%) were inconclusive and 11 (16.4%) had no evidence of coeliac disease. Of those who did not undergo biopsy 11 (33.0%) were known to have CD or refused D2 biopsy. In 22 (21.6%) patients gastroenterological follow-up had not been arranged, of these 16 (72.7%) tests had been arranged in primary care.

Conclusion In this study 1.6% of those tested had serology suggestive of coeliac disease, this is marginally larger than expected by chance and suggests that testing was not appropriately targeted. Surprisingly 21.6% of positive tests did not have appropriate follow-up arranged. We suspect these findings are not confined to our institution. Our findings suggest that engagement and education of non-gastroenterology colleagues, particularly those in primary care is important in order that patients receive appropriate treatment and conform to AGA, BSG and NICE guidelines. We plan in future that all positive coeliac serology test reports be issued with the advice that referral to a gastroenterologist is recommended.

Competing interests None declared.

References 1. AG1. Recognition and Assessment of Coeliac Disease, Clinical Guidelines, CG 86. Issued: May 2009.

2. AGA Institute. AGA Institute medical position statement on the diagnosis and management of coeliac disease. Gastroenterology 2006;131:1997–80.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.